SCOPE 2024

Advarra at SCOPE - excited to hear about site and sponsor technology coordination

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags SCOPE 2024 Clinical trials Clinical trial Data management Patient centricity

Elisa Cascade is chief product officer at Advarra, a business that says it aims to advance the way clinical research is conducted by bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration.

The company provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance and is advancing clinical trials to make them safer, smarter, and faster.

Why do you think it is important to attend SCOPE?

SCOPE’s size and focus on clinical operations – both best practices today and future innovations to monitor – makes it the one place where sponsors, CROs, technology providers, regulatory experts, and others can connect and have meaningful conversations.

Advarra Elisa Cascade

What do you hope to achieve this year while you are there?

I am excited to hear what’s new and contribute to the conversation, especially in site and sponsor technology coordination. Advarra always brings a large team to SCOPE so that we can learn from and engage with others on how to connect the clinical technology ecosystem to reduce friction for our sites, and drive efficiencies and compliance for sponsors and CROs.

Do you have an inkling what the buzz theme will be this year?

I am sure we will hear a lot about innovation in AI among other topics at SCOPE. However, what I am interested in hearing most is not the theoretical but instead actual case examples of what is working with a positive return on investment, and what has not succeeded in driving efficiency, compliance, or other benefits.

For those who have never attended SCOPE before, what would you say to entice them?

SCOPE provides an opportunity for both individuals who are new to the industry as well as veterans such as me to engage in detailed conversations on patient qualification and enrollment, site-sponsor technology, and the upcoming U.S. shift to Single IRB to name a few topics.  Please visit us at Advarra’s booth 1001 to say hello and hear how we’re working hard to support these areas and more.

What part of it are you looking forward to the most?

For me, SCOPE is a time to catch up with long-time friends and industry leaders. Professionally, I’m always excited to engage in meaningful conversations with individuals representing differing perspectives. I’d like to invite you to my session on Monday at 12:20 p.m. on prioritizing the site and patient technology experience in trial planning to chat more! 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us